Literature DB >> 27418559

Nerve fibers and endometriotic lesions: partners in crime in inflicting pains in women with endometriosis.

Dingmin Yan1, Xishi Liu2, Sun-Wei Guo3.   

Abstract

One of major objectives in treating endometriosis is to alleviate pain since dysmenorrhea and other types of pain top the list of complaints from women with endometriosis who seek medical attention. Indeed, endometriosis-associated pain (EAP) is the most debilitating of the disease that negatively impacts on the quality of life in affected women, contributing significantly to the burden of disease and adding to the substantial personal and societal costs. Unfortunately, the mechanisms underlying the EAP are still poorly understood. In the last two decades, one active research field in endometriosis is the investigation on the distribution and genesis of nerve fibers in eutopic and ectopic endometrium, and the attempt to use endometrial nerve fiber density for diagnostic purpose. Since EAP presumably starts with the terminal sensory nerves, in or around endometriotic lesions, that transduce noxious mediators to the central nervous system (CNS) which ultimately perceives pain, this field of research holds the promise to elucidate the molecular mechanisms underlying the EAP, thus opening new avenues for novel diagnostics and therapeutics. In this review, we shall first briefly provide some basic facts on nerve fibers, and then provide an overview of some major findings in this filed while also note some conflicting results and expose areas in need of further research. We point out that since recently accumulated evidence suggests that endometriotic lesions are wounds undergoing repeated tissue injury and repair, the relationship between endometriotic lesions and nerve fibers is not simply unidirectional, i.e. lesions promote hyperinnervations. Rather, it is bidirectional, i.e. endometriotic lesions and nerve fibers engage active cross-talks, resulting in the development of endometriosis and pain. That is, nerve fibers and endometriotic lesions are actually partners in crime in inflicting pains in women with endometriosis, aided and abetted possibly by other culprits, some yet to be identified. We provide a list of possible perpetrators likely to be involved in this crime. Finally, we discuss possible implications when viewing the relationship from this vista.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cross-talk; Endometriosis; Nerve fibers; Pain

Mesh:

Year:  2016        PMID: 27418559     DOI: 10.1016/j.ejogrb.2016.06.017

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  11 in total

1.  HORMONAL THERAPY IN WOMEN OF REPRODUCTIVE AGE WITH ENDOMETRIOSIS: AN UPDATE.

Authors:  A A Gheorghisan-Galateanu; M L Gheorghiu
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Apr-Jun       Impact factor: 0.877

2.  Central Sensitization-Related Changes in Brain Function Activity in a Rat Endometriosis-Associated Pain Model.

Authors:  Ping Zheng; Shuangzheng Jia; Dalong Guo; Sikai Chen; Wen Zhang; Aoshuang Cheng; Weijie Xie; Guibo Sun; Jinhua Leng; Jinghe Lang
Journal:  J Pain Res       Date:  2020-01-13       Impact factor: 3.133

3.  Reduced vagal tone in women with endometriosis and auricular vagus nerve stimulation as a potential therapeutic approach.

Authors:  Meihua Hao; Xishi Liu; Peijing Rong; Shaoyuan Li; Sun-Wei Guo
Journal:  Sci Rep       Date:  2021-01-14       Impact factor: 4.379

4.  Eliapixant is a selective P2X3 receptor antagonist for the treatment of disorders associated with hypersensitive nerve fibers.

Authors:  Adam J Davenport; Ioana Neagoe; Nico Bräuer; Markus Koch; Andrea Rotgeri; Jens Nagel; Alexis Laux-Biehlmann; Frederic Machet; Anne-Marie Coelho; Susan Boyce; Nikisha Carty; Mark J Gemkow; Stephen D Hess; Thomas M Zollner; Oliver M Fischer
Journal:  Sci Rep       Date:  2021-10-06       Impact factor: 4.379

5.  Endometriosis pain and epithelial neutrophil activating peptide-78 levels.

Authors:  Barbara Gardella; Mattia Dominoni; Andrea Gritti; Anna Arrigo; Silvia Antonucci; Giulia Vittoria Carletti; Valentina Musacchi; Giampiero Pietrocola
Journal:  Sci Rep       Date:  2022-02-25       Impact factor: 4.996

6.  Comparative analysis of molecular signatures suggests the use of gabapentin for the management of endometriosis-associated pain.

Authors:  Brice Bellessort; Anne Bachelot; Virginie Grouthier; Camille De Lombares; Nicolas Narboux-Neme; Paolo Garagnani; Chiara Pirazzini; Simonetta Astigiano; Luca Mastracci; Anastasia Fontaine; Gladys Alfama; Evelyne Duvernois-Berthet; Giovanni Levi
Journal:  J Pain Res       Date:  2018-04-10       Impact factor: 3.133

7.  Decreased Level of Neurotrophic Factor Neuritin 1 in Women with Ovarian Endometriosis after Receiving Gonadotropin-Releasing Hormone Agonist Treatment.

Authors:  Endah Rahmawati; Wei-Chung Vivian Yang; Yen-Ping Lei; Pawan Kumar Maurya; Huei-Wen Chen; Chii-Ruey Tzeng
Journal:  Int J Mol Sci       Date:  2019-09-05       Impact factor: 5.923

8.  Early maternal separation accelerates the progression of endometriosis in adult mice.

Authors:  Qiqi Long; Xishi Liu; Sun-Wei Guo
Journal:  Reprod Biol Endocrinol       Date:  2020-06-12       Impact factor: 5.211

Review 9.  Purinergic Signaling in Endometriosis-Associated Pain.

Authors:  Carla Trapero; Mireia Martín-Satué
Journal:  Int J Mol Sci       Date:  2020-11-12       Impact factor: 5.923

Review 10.  Cancer driver mutations in endometriosis: Variations on the major theme of fibrogenesis.

Authors:  Sun-Wei Guo
Journal:  Reprod Med Biol       Date:  2018-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.